Hydrocortisone increases the number of insulin receptors at the surface of human cultured lymphocytes (IM-9 line) without altering the degradation of the mature receptor subunits. To elucidate the effect of glucocorticoids on the biosynthesis of the insulin receptor of IM-9 cells, we preincubated cells in the presence or absence of hydrocortisone (1.4 X 10' M) and measured the incorporation of radiolabeled sugars into the insulin receptor components.
Introduction
The insulin receptor is a critical point at which cellular responsiveness to insulin is determined. While the process of "down" regulation of insulin receptors has been studied in detail (1) , there is little information on mechanisms to augment receptor concentration. It has been shown that corticosteroids will increase the concentration of insulin receptors on IM-9
Dr. Rouiller received a fellowship from the Swiss National Science Foundation. Dr. McElduff received a C. J. Martin Fellowship from the National Health and Medical Research Council of Australia. cultured human lymphocytes (2) . The process is presumably mediated through the corticosteroid receptor (3) and is timeand dose-dependent (4) . Further , it has been shown that when cell surface receptors were labeled, their disappearance rate was not decreased by corticosteroids. This led to the conclusion that corticosteroids increase receptor synthesis (4) .
Recently, it has been shown that the insulin receptor is synthesized by way of a single chain precursor (5, 6) . This proreceptor is then proteolytically cleaved and undergoes further posttranslational processing before insertion of the mature subunits into the plasma membrane. Our present studies take advantage of the fact that the insulin receptor is a glycoprotein and that the incorporation of radioactive sugars can be used to study the earliest events in the biosynthesis of the receptor (6, 7) . The results show that hydrocortisone augments the synthesis of the receptor precursor or proreceptor, providing direct evidence that in IM-9 cultured human lymphocytes corticosteroids increase the concentration of insulin receptors by inducing receptor synthesis.
Methods
Cell culture and hydrocortisone treatment Cultured human IM-9 lymphocytes (1.5-2 X 106 cells/ml) were grown in RPMI 1640 medium (Biofluids, Rockville, MD) containing 25 mM Hepes (Sigma Chemical Co., St. Louis, MO). On the day of the experiment, cells were resuspended at 2.5 X 106 cells/ml in fresh medium containing 5 mM glucose and 1.4 X 101 M (0.5 jtg/ml) Pulse-chase labeling. These experiments were carried out as previously described by Hedo et al. (6) . Briefly, at the end ofthe preincubation period, the cells were washed twice with phosphate-buffered saline (PBS), incubated 30 min in glucose-free medium, and concentrated 10-fold to 2.5 X 107 cells/ml; 0.5 mCi/ml of either D-[2-3H(N)]mannose or D-[l,6-3H(N)]glucosamine hydrochloride (specific activity, 47 Ci/mmol [New England NuclearD) was then added. After a 15-min incubation at 370C (the pulse), the cells were quickly washed three times with PBS, resuspended at 2 X 106 cells/ml in complete medium containing 2 mM of either mannose or glucosamine-hydrochloride, and incubated at 370C for the stated periods of time (the chase). Until the end of the chase, all the washing buffers and the culture-media contained either 1.4 X 10-M hydrocortisone or the carrier alone (control).
Cell solubilization
At the end of the biosynthetic incubation period, the cells were counted using a Levy-Hausser Chamber. Their viability, estimated by trypan blue exclusion, was always >95%. They were washed three times with cold PBS, collected by centrifugation, and solubilized in a NaCl (150 mM) Hepes (50 mM) buffer, pH 7.6, containing 1% Triton X-100, 2 mM phenylmethylsulfonyl fluoride (Sigma Chemical Co.), and 50 mg% a-2-macroglobulin (Boehringer-Mannheim Biochemicals, Indianapolis, IN), for 30 min on ice with continuous stirring. The mixture was clarified by ultracentrifugation (200,000 g, 4VC for I h). Aliquots (10 Ml) were taken both before ultracentrifugation and from the soluble extracts for the measurement of total and trichloroacetic acid (TCA)-precipitable radioactivity within the samples.
Immunoprecipitation and electrophoresis
The solubilized insulin-receptors were immunoprecipitated as previously described (7, 8) : the ultracentrifugation supernatant was incubated overnight at 4VC with either anti-receptor anti-serum "Bd" (titer 1:100), or normal patient serum (titer 1:40). These concentrations of serum were used to obtain approximately the same amount ofCoomassie Blue stainable IgG bands on the gels. The immune complexes were adsorbed with Pansorbin (Calbiochem-Behring Corp., La Jolla, CA), washed with the NaCI-Hepes buffer at pH 7.6, containing 1% Triton X-100 and 0.1% SDS, dissociated by boiling for 5 min in 2% sodium dodecyl sulfate (SDS), 0.1 M dithiothreitol, 0.5 M mercaptoethanol, 0.002% bromophenol blue, and 10 mM phosphate buffer, at pH 7, and recovered in the supernatant after centrifugation at 15,000 g for 5 min and recovered in the supernatant after centrifugation at 15,000 g for 5 min. The samples were kept frozen at -70°C until electrophoresis
Electrophoresis was performed by a modification of Laemmli (9), using 7.5% polyacrylamide and 0.1% SDS slab gels as previously described (7, 8) . Immunoprecipitates from 2.5 X 10 cells were used for applications to each lane of the gel. Before being dried, the gels were treated with "Enlightning," an autoradiographic enhancer (New England Nuclear). The dried gels were autoradiographed on Kodak XOmat AR film (Eastman Kodak Co., Rochester, NY) at -70°C for -3 wk. Quantitative estimates of the radioactivity in the bands of interest were obtained by eluting the sliced bands overnight in 3% protosol in Econofluor (New England Nuclear) at 37°C; the radioactivity was then counted in a scintillation counter.
Results
Steady-state labeling of the insulin receptors. Since, by using both equilibrium binding analysis and immunoprecipitation of surface-labeled receptors, it has been shown that hydrocortisone increases the number of cell surface receptors for insulin on IM-9 cultured human lymphocytes, in order to pursue our inquiry we first determined the effect of the corticosteroid on the level of biosynthetically labeled receptors. After a 6-h preincubation with or without 1.4 X 10-6 M hydrocortisone, IM-9 cells were incubated with [3H]mannose in the presence or absence of hydrocortisone for variable periods of time. At selected times thereafter, cells were harvested and solubilized. The soluble material was immunoprecipitated with antireceptor or control serum and the immunoprecipitate applied to a polyacrylamide gel for electrophoresis. There was a latency of -6 h before radioactivity was detected in the four previously described insulin receptor components, i.e., with apparent molecular weights of 210,000, 190,000, 135,000, and 95,000 (Fig. 1) . Radioactivity increased in these bands from 6 to 22 h and then declined. In hydrocortisone-treated cells, however, the insulin proreceptor (190,000 mol wt) and the mature subunits were always more heavily labeled than in the untreated cells.
Pulse-chase studies. To investigate whether the hydrocortisone-induced increase in insulin receptors was due to stimulation of synthesis or receptor stabilization, we studied the earliest events in insulin receptor biosynthesis, using pulsechase techniques. Again, cells were preincubated for 6 h in the presence or absence of hydrocortisone. To allow early detection of insulin receptor subunits, the radiolabel and the cells were highly concentrated for a short pulse (15 min), then quickly washed and resuspended at regular concentrations for the chase in the presence of an excess of nonradioactivie label.
In control cells, after 30 min of chase, the 190,000-mol-wt high mannose precursor of the insulin receptor was the most intensively labeled component (Fig. 2 and Fig. 3, top) . As previously shown (6) , the incorporation into this band was further increased at 60 min and decreased thereafter.
In hydrocortisone-treated cells, at any time point the labeling of all components was greater than in the control (258% at 30 min, 283% at 60 min). The disappearance rate, estimated by extrapolation of Fig. 3 , was not different from control (half-life = 45 min). The processing of the 190,000-mol-wt proreceptor to the mature subunits is reflected by the gradual increase in labeling of the 135,000-and 95,000-mol-wt subunits throughout the chase (Fig. 2, and Fig. 3, bottom) . Again, at all time points the incorporation was greater in hydrocortisone-treated cells than in control (261±48% for the 1 35,000-mol-wt subunit, 229±44% for the 95,000-mol-wt subunit; mean increase± 1 SD).
Results that were similar but somewhat less distinct were obtained at 30 min when glucosamine was used as the labeled sugar (data not shown).
Effect ofhydrocortisone on cell growth and mannose incorporation. Though it has been reported that glucocorticoids do not alter the growth pattern of IM-9 cells (10), we wished to verify this under our experimental conditions. The presence of hydrocortisone did not significantly affect cell growth (cell number X 10-6/ml = 2.76±1.05 for hydrocortisone-treated cells and 2.83±0.86 for control, mean± 1 SD; P = NS).
Further, we wished to verify that the uptake of [3H]mannose was not altered by hydrocortisone, which could alter the initial pool size of the labeled material. We found that the amount of radioactivity incorporated into either the whole cells or the soluble extracts was similar in the presence or absence of hydrocortisone (Table I) . Thus, within the sensitivity of the methodology used we were unable to detect a change in the mannose pool size.
Discussion
Our data show that hydrocortisone increased the incorporation of radioactive mannose into the insulin receptor precursor and mature subunits in IM-9 cultured human lymphocytes. This effect was not due to stimulation of cell division. Further brought about by corticosteroids is not fully elucidated by our experiments. One recent study has suggested a stimulatory effect of steroids upon the posttranslational glycosylation of proteins (11). This cannot be an explanation for our data, since the labeling of the high-mannose, endo H-sensitive precursor (190,000 mol wt), which has not yet undergone posttranslational modification, is also increased in steroidtreated cells. Second, it is thought that the small increase in apparent molecular weight of the 135,000-mol wt subunit in the course of a chase is due to the posttranslational addition of complex carbohydrates (7) . There was no further increase in apparent molecular weight of the subunits from treated cells, despite a 2. Fig. 3) .
In five independent studies using cultured cells, steroids have been shown to increase insulin receptor concentration. These include IM-9 cells (2, 4), U-937 monocytes (13), bladder carcinoma cells (14) , rat hepatocytes (15) , and 3T3-C2 mouse fibroblasts (16) . Using the heavy isotope density shift technique, Salhanick et al. (15) showed that the corticosteroid-induced increase in insulin receptors on primary culture of rat hepatocytes was due to an increase in receptor synthesis. These results are fully consistent with our data. Using the same density shift method, Knutson et al. (16) demonstrated a corticosteroid-induced increase in insulin receptor of 3T3-C2 mouse fibroblasts, but concluded that the increase was not related to an increase synthesis but rather to a decreased degradation rate. These results suggest that there may be species or tissue differences.
There is a conflicting and confusing array of studies both in vivo and in vitro, in animal models (17, 18) and in humans (2, (19) (20) (21) (22) , concerning the effect of corticosteroids on the insulin receptor. No attempt will be made to reconcile these results, but a few generalizations seem warranted: In vivo corticosteroids may induce the synthesis of insulin receptors on certain types of cells. At the same time, the drug increases circulating insulin concentrations (2, 4) , which acts to "down" regulate the receptor. The net effect of these competing phenomena will depend on a variety of circumstances, such as duration of study, dose of drug, and many other factors. Second, even in the in vitro setting where steroids have been used to induce insulin resistance, the apparent resistance to receptor "down" regulation may simply be due to the effect of the drug to stimulate receptor synthesis (23) .
The major significance ofthe present study is to demonstrate a system in which the action of a drug or other agent can be tested for its ability to augment insulin receptor synthesis. Hydrocortisone represents the first agent that has been shown to stimulate the biosynthesis of the insulin proreceptor.
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